Comparing GreenLight PVP and HoLEP Beyond 5 Years: A Systematic Review of Long-Term Functional Outcomes and Reoperation Rates - Beyond the Abstract ...
Robotic versus Open Cystectomy with Ileal Conduit for the Management of Neurogenic Bladder: A Comparative Study - Beyond the Abstract ...
Barriers and facilitators to prostate cancer healthcare in Black men in the UK: from diagnosis to survivorship. December 29, 2025 Radical prostatectomy outcomes in patients with PI-RADS 5 lesions and ...
Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract ...
December 16, 2025 Is the era within which a TURP was performed associated with differences in reoperation rates, specific surgical side effects, or the requirement for BPH medicat ...
Prostate cancer, while commonly diagnosed in early forms, remains the second leading cause of cancer mortality in the United States and Europe. 1 For patients who die of prostate cancer, some will be ...
Ariana Smith discusses autologous pubovaginal slings for stress urinary incontinence treatment, highlighting this century-old procedure as a durable mesh-free alternative that remains underutilized in ...
David Staskin discusses the COURAGE trial, a phase three study evaluating the efficacy of Vibegron, a beta-3 adrenergic receptor agonist, in men with BPH and persistent OAB symptoms despite ...
Read the Full Video Transcript Diane Newman: Hello, I'm Diane Newman. I'm a continence nurse specialist and I'm an adult nurse practitioner. I've been practicing in a pelvic floor dysfunction, seeing ...
Combination Lenvatinib-Tislelizumab for Fumarate Hydratase-Deficient Renal Cell Carcinoma - Wen Kong
Pedro Barata interviews Wen Kong about lenvatinib plus tislelizumab for first-line treatment of fumarate hydratase (FH)-deficient renal cell carcinoma. Dr. Kong shares results from a single-center ...
Sam Chang speaks with Sarah Psutka about an expanded access program for cretostimogene (CG0070) in BCG-unresponsive non-muscle invasive bladder cancer. Dr. Psutka explains that this oncolytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback